R&D Center
The Company has established an open technology platform dedicated to creating a technological empowerment platform for the pharmaceutical health industry, aspiring to facilitate API manufacturing companies, pharmaceutical production enterprises, chemical manufacturing companies, and entrepreneurs to lower R&D thresholds, improve R&D efficiency, and facilitate the early introduction of more new and effective drugs to benefit patients globally. The Company has established two major R&D centers in Guangzhou and Wuhan, mainly engaged in the R&D of APIs, pharmaceutical intermediates, pharmaceutical preparations, and fine chemical products. The Wuhan R&D center spans an area of 1,500 square meters, housing over 150 R&D personnel, including nine doctor’s degree holders and 41 master’s degree holders. Over 95% of the employees have at least a bachelor’s degree. Our platform currently supports over 100 R&D projects from more than 50 partners. We have pre-production test and large-scale production bases in Chifeng City, Inner Mongolia, China.